+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Idiopathic pulmonary fibrosis: molecular mechanisms and possible therapeutic strategies

Idiopathic pulmonary fibrosis: molecular mechanisms and possible therapeutic strategies

Archivum Immunologiae et Therapiae Experimentalis 48(6): 539-545

Idiopathic pulmonary fibrosis (IPF) is a devastating disease with an almost universally terminal outcome. In recent years much insight has been gained into the pathogenesis of IPF from both a bleomycin mice-model as well as ex vivo human tissue studies. Alveolar damage and inflammation of unknown etiology, eventually leading to interstitial fibrosis, characterize IPF. Apoptosis has emerged as an important factor in the pathogenesis of IPF. This review will outline the current understanding of the immunological and molecular mechanisms underlying IPF and discuss new therapeutic strategies.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 046320583

Download citation: RISBibTeXText

PMID: 11197609

Related references

Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. Current Pharmaceutical Design 11(30): 3943-3971, 2005

Molecular Mechanisms of and Possible Treatment Strategies for Idiopathic Pulmonary Fibrosis. Current Pharmaceutical Design 11(30): 3943-3971, 2005

New therapeutic strategies in idiopathic pulmonary fibrosis. Archivos de Bronconeumologia 40 Suppl 6: 16-22, 2005

IL-13 and idiopathic pulmonary fibrosis: Possible links and new therapeutic strategies. Pulmonary Pharmacology and Therapeutics 45: 95-100, 2017

New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet 380(9842): 680-688, 2012

Molecular mechanisms in progressive idiopathic pulmonary fibrosis. Annual Review of Medicine 64: 265-276, 2013

Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets. International Journal of Molecular Sciences 20(3), 2019

Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proceedings of the National Academy of Sciences of the United States of America 106(10): 3958-3963, 2009

Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models. Pharmaceutical Biology 55(1): 450-455, 2017

Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newborn. Italian Journal of Pediatrics 41: 6, 2016

Molecular Mechanisms and Therapeutic Strategies of Chronic Renal Injury: The Role of Nuclear Factor B Activation in the Development of Renal Fibrosis. Journal of Pharmacological Sciences 100(1): 17-21, 2006

Molecular mechanisms and therapeutic strategies of chronic renal injury: the role of nuclear factor kappaB activation in the development of renal fibrosis. Journal of Pharmacological Sciences 100(1): 17-21, 2006

Pathogenesis of idiopathic interstitial pneumonia/idiopathic pulmonary fibrosis: cellular and molecular biology of the disease. Nihon Kyobu Shikkan Gakkai Zasshi 31(Suppl.): 20-31, 1993

Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies. Respiration; International Review of Thoracic Diseases 93(6): 379-395, 2017

Design, Rationale, Methodology, and Aims of a Greek Prospective Idiopathic Pulmonary Fibrosis Registry: Investigating Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF). Respiration; International Review of Thoracic Diseases 96(1): 41-47, 2018